The molecular mechanisms of mitochondrial behavior.
线粒体行为的分子机制。
基本信息
- 批准号:8672957
- 负责人:
- 金额:$ 23.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-16 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressApoptosisApoptoticBax proteinBehaviorBiochemicalBiological AssayCardiacCell DeathCell physiologyCellsCharacteristicsChimeric ProteinsChronicComplexCoupledDataDeletion MutationDisease ProgressionDynaminEmbryoEventFoundationsGTP BindingGrantGuanosine TriphosphateGuanosine Triphosphate PhosphohydrolasesHeartHeart DiseasesHydrolysisIn VitroKnowledgeLightLinkMammalsMapsMediatingMembraneMembrane FusionMicrotubulesMitochondriaMolecularMovementMyocardial InfarctionNatureNeurodegenerative DisordersOrganellesOrganismPathway interactionsPhysiologicalPlayProcessPropertyProtein FamilyProteinsRegulationRelative (related person)RoleShapesSignal PathwaySignal TransductionTestingTherapeuticTimeTissuesTranslatingabstractingbasecell motilitychemical geneticsdrug developmentfusion genein vitro Assayinsightmembernovelprotein functionresearch studytherapeutic development
项目摘要
Project Summary/Abstract:
Mitochondrial fusion regulates the shape, distribution and function of the organelle and plays critical roles in
protection from cell death and therefore offers a valid target for theurapeutic approaches to protect the heart
from progression of disease or myocardial infarction events. Mitochondrial fusion is mediated by members of
the dynamin related protein (DRP) family, large GTPases that, through their ability to self-assemble and
hydrolyze GTP, control membrane remodeling events. In mammals, MFN1 and MFN2 function in place of a
single outer membrane DRP in simple organisms, both are expressed ubiquitously but the relative expression
level of each varies in a tissue dependent manner. Although MFN1 and MFN2 both function in mitochondrial
fusion, they are not completely redundant, although the nature of the functional differences are not known. Our
data indicate that the MFN1-MFN2 heterotypic trans complex is significantly more efficacious for fusion than
either homotypic complex. From this, we predict that MFN1 and MFN2 have distinct molecular properties and
that the functional significance of the two outer membrane DRPs in mammals is to provide a relatively simple
regulatory fusion mechanism via their respective and relative expression levels. Further, data suggest that
specific regulatory mechanisms exist, as we have shown that soluble Bax stimulates only MFN2 homotypic
complexes. In order to understand the functional significance of two outer membrane fusion proteins and the
regulatory mechanisms that govern their activity, we propose to characterize the biochemical properties of
each DRP including GTP binding, GTP hydrolysis and complex assembly. These biochemical approaches
together will determine the mechanistic basis for why MFN1 only, MFN2 only and MFN1/MFN2 mediated
fusion efficiencies are distinct and will likely point to why and how they are distinctly regulated in cells. To
explore what properties of MFN2 are modulated by the pro-apoptotic Bcl2 protein Bax, we will test the effect of
Bax on the biochemical properties of MFN2, of particular significance in the heart where MFN2 is the
predominantly expressed fusion DRP. We will further characterize the regulation of fusion by Bax through
identification of interaction domains and exploring their functional significance in vitro and in cells. Bax also
negatively effects mitochondrial fusion following activation by apoptotic signals and we will investigate whether
the inhibition of fusion is direct or mediated through outer membrane permeabilization. As observed with the
apoptotic pathway and mitochondrial dynamics, an interdependence also exists between mitochondrial fusion
and mitochondrial motility, but the significance of this is relatively unexplored. We propose that mitochondrial
tethering to microtubules and short range motility are both important regulators of mitochondrial fusion. We will
determine the role that mitochondrial movement and tethering play in regulating mitochondrial fusion and
investigate the molecular basis for the requirement of MFNs in these processes using an in vitro mitochondrial
fusion-motility assay and complimentary biochemical approaches.
项目总结/文摘:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Suzanne C Hoppins其他文献
Suzanne C Hoppins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Suzanne C Hoppins', 18)}}的其他基金
Determining the mechanism of mitochondrial outer membrane fusion
确定线粒体外膜融合的机制
- 批准号:
10619656 - 财政年份:2017
- 资助金额:
$ 23.7万 - 项目类别:
Determining the mechanism of mitochondrial outer membrane fusion
确定线粒体外膜融合的机制
- 批准号:
10441835 - 财政年份:2017
- 资助金额:
$ 23.7万 - 项目类别:
Determining the mechanism of mitochondrial outer membrane fusion
确定线粒体外膜融合的机制
- 批准号:
9238391 - 财政年份:2017
- 资助金额:
$ 23.7万 - 项目类别:
Determining the mechanism of mitochondrial outer membrane fusion
确定线粒体外膜融合的机制
- 批准号:
10798533 - 财政年份:2017
- 资助金额:
$ 23.7万 - 项目类别:
Determining the mechanism of mitochondrial outer membrane fusion
确定线粒体外膜融合的机制
- 批准号:
10807828 - 财政年份:2017
- 资助金额:
$ 23.7万 - 项目类别:
Determining the mechanism of mitochondrial outer membrane fusion
确定线粒体外膜融合的机制
- 批准号:
9701515 - 财政年份:2017
- 资助金额:
$ 23.7万 - 项目类别:
Determining the mechanism of mitochondrial outer membrane fusion
确定线粒体外膜融合的机制
- 批准号:
10090478 - 财政年份:2017
- 资助金额:
$ 23.7万 - 项目类别:
The molecular mechanisms of mitochondrial behavior.
线粒体行为的分子机制。
- 批准号:
8722591 - 财政年份:2013
- 资助金额:
$ 23.7万 - 项目类别:
The molecular mechanisms of mitochondrial behavior.
线粒体行为的分子机制。
- 批准号:
8875045 - 财政年份:2013
- 资助金额:
$ 23.7万 - 项目类别:
The molecular mechanisms of mitochondrial behavior.
线粒体行为的分子机制。
- 批准号:
8111493 - 财政年份:2011
- 资助金额:
$ 23.7万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10596657 - 财政年份:2021
- 资助金额:
$ 23.7万 - 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10417219 - 财政年份:2021
- 资助金额:
$ 23.7万 - 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2015
- 资助金额:
$ 23.7万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2014
- 资助金额:
$ 23.7万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
- 批准号:
nhmrc : 1059331 - 财政年份:2014
- 资助金额:
$ 23.7万 - 项目类别:
Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2013
- 资助金额:
$ 23.7万 - 项目类别:
Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
- 批准号:
251802 - 财政年份:2012
- 资助金额:
$ 23.7万 - 项目类别:
Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
- 批准号:
191299 - 财政年份:2009
- 资助金额:
$ 23.7万 - 项目类别:
Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
8075522 - 财政年份:2009
- 资助金额:
$ 23.7万 - 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
7676912 - 财政年份:2009
- 资助金额:
$ 23.7万 - 项目类别:














{{item.name}}会员




